REL divergent transcript (REL-DT)

REL divergent transcript is a member of the long intergenic non-coding RNA (lincRNA) family, defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap coding genes[4]. The REL-DT gene does not produce a protein and instead acts at the RNA level, where lincRNAs commonly function in remodeling chromatin, regulating transcription (often epigenetically), and acting as scaffolds for protein complexes in the nucleus[4]. While the specific functions of REL-DT itself are not yet characterized in detail, one clinical study identifies the FLJ16341 locus within a deletion region in 2p16.1 microdeletion syndrome, suggesting its expression in the brain and proposing it as a candidate gene associated with syndrome features such as developmental and intellectual disability[5]. As with other lincRNAs, REL-DT may contribute to tissue-specific gene regulation and chromatin architecture, potentially impacting disease risk, but there is no evidence that it serves as a canonical therapeutic target or is directly targeted by drugs[4][5][3][1].

Other names

FLJ16341LINC01185long intergenic non-protein coding RNA 1185